<DOC>
	<DOCNO>NCT01820858</DOCNO>
	<brief_summary>This randomize trial study efficacy safety chemotherapy compare radiation therapy alone adjuvant treatment operation Patients high risk Stage I endometrial carcinoma .</brief_summary>
	<brief_title>The Efficacy Safety Postoperative Adjuvant Treatment Patients With High-risk Stage I Endometrial Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>FIGO stage : Ⅰ , endometrial carcinoma ; Female , Chinese woman ; Initial treatment stag surgery ; Pathological diagnosis : Endometrial adenocarcinoma ; Pathologic examination meet follow one indication adjuvant therapy : ① histopathological grade poorly differentiate : G3 ; ② ≥50 % myometrial invasion ; ③ vascular space involvement ; No prior treatment ; Provide write informed consent . Unable receive surgery and/or unsuitable radiotherapy chemotherapy ; Family history ovarian cancer ; Suffering malignancy ; Concurrently participate clinical trial ; Unable unwilling sign informed consent ; Unable unwilling abide protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>